Immune response to heart attack worsens atherosclerosis, increases future risk
A heart attack doesn't just damage heart muscle tissue by cutting off its blood supply, it also sets off an inflammatory cascade that worsens underlying atherosclerosis, actively increasing the risk for a future heart attack. ...
Cardiology
Jun 27, 2012 |
not rated yet |
0
|
Have no fear: Most cases of thyroid cancer do not affect survival
Research presented at the Society of Nuclear Medicine's 59th Annual Meeting reveals that patients with differentiated thyroid cancer live as long as people in perfect health, unless they are in the minority and have reached ...
Cancer
Jun 11, 2012 |
not rated yet |
0
Studies show that pancreatic cancer can run but not always hide from the immune system
A pair of recent studies describes how pancreatic cancer cells produce a protein that attracts the body's immune cells and tricks them into helping cancer cells grow. The research, published by Cell Press in the June 12th ...
Cancer
Jun 11, 2012 |
not rated yet |
0
|
Newly identified protein function protects cells during injury
Scientists have discovered a new function for a protein that protects cells during injury and could eventually translate into treatment for conditions ranging from cardiovascular disease to Alzheimer's.
Medical research
Jun 07, 2012 |
not rated yet |
0
|
Head lice beginning to show permethrin resistance
(HealthDay) -- Although live head lice obtained from school-aged children in Paris remain susceptible to the insecticide malathion, approximately 14 percent have been found to be resistant to permethrin, suggesting ...
Diseases, Conditions, Syndromes
Jun 05, 2012 |
not rated yet |
0
Marked for destruction: Newly developed compound triggers cancer cell death
The BCL-2 protein family plays a large role in determining whether cancer cells survive in response to therapy or undergo a form of cell death known as apoptosis. Cells are pressured toward apoptosis by expression of pro-apoptotic ...
Cancer
May 24, 2012 |
5 / 5 (1) |
0
Drug kills cancer cells by restoring faulty tumor suppressor
A new study describes a compound that selectively kills cancer cells by restoring the structure and function of one of the most commonly mutated proteins in human cancer, the "tumor suppressor" p53. The research, published ...
Cancer
May 14, 2012 |
5 / 5 (1) |
0
Clinical trials often fall short
Clinical studies registered in clinicaltrials.gov between 2007-2010 are dominated by small, single-center trials and contain significant heterogeneity (different in nature, difficult to compare) in methodological approaches, ...
Other
May 01, 2012 |
not rated yet |
0
The role of inflammation on atherosclerosis
(Medical Xpress) -- European scientists dig into atherosclerotic plaque formation processes to investigate the part played by inflammation and vascular wall remodelling.
Medical research
May 01, 2012 |
5 / 5 (2) |
0
Researchers identified a protein useful in predicting the risk of pulmonary metastases in breast cancer patients
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have shown that breast cancer cells that metastasize to the lung express a higher level of the protein peroxiredoxin 2 (PRDX2). The study suggests that ...
Cancer
Apr 10, 2012 |
5 / 5 (1) |
0
Protective gene in fat cells may lead to therapeutic for Type 2 diabetes
In a finding that may challenge popular notions of body fat and health, researchers at Beth Israel Deaconess Medical Center (BIDMC) have shown how fat cells can protect the body against diabetes. The results may lead to a ...
Medical research
Apr 01, 2012 |
4.8 / 5 (6) |
0
|
Study may lead to new treatments for prostate cancer
A recent study conducted at Marshall University may eventually help scientists develop new treatments for prostate cancer, the most common malignancy in American men.
Cancer
Mar 21, 2012 |
not rated yet |
0
Research provides new hope for those suffering from Crohn's disease
Researchers from the Hotchkiss Brain Institute (HBI) and the Snyder Institute for Chronic Diseases at the University of Calgary's Faculty of Medicine have discovered a pathway that may contribute to the symptoms related to ...
Inflammatory disorders
Mar 21, 2012 |
4 / 5 (1) |
0
|
Bright future ahead for antibody cancer therapy
Antibodies, once touted as the "magic bullets" of cancer care, are now fulfilling that promise and more advances are on the way, say cancer researchers at the Georgetown Lombardi Comprehensive Cancer Center
Cancer
Mar 15, 2012 |
5 / 5 (4) |
0
|
New research could provide roadmap for more effective drug discovery for cystic fibrosis
A recent study led by Gergely Lukacs, a professor at McGill University's Faculty of Medicine, Department of Physiology, and published in the January issue of Cell, has shown that restoring normal function to the mutant gene p ...
Medical research
Mar 12, 2012 |
5 / 5 (1) |
0
